Remarkably, the spectacular gain of survival acquired by AML blasts facing a syntenin‐KO environment (Fig 2B) is associated with a twofold increase in tumor translational activity (Fig 3D). This evidence concerns the gene SDCBP and acute myeloid leukemia.